A very disappointing outcome, with the downside far exceeding my calculated risk. Live and learn. This is terrible news before Christmas, and it raises for me serious questions about the company's future. At this point, I believe the company needs to make swift and difficult cost cutting decisions. We’ve become a very low-cap company that can no longer sustain our current overheads. Considerations should include the size and cost of the Board, our highly paid CEO with incentives that don’t seem to align with shareholders, and the general business overheads (including the talented people we’ve recently hired).
Unfortunately, I suspect we’ll take the usual route: burning through our cash reserves to over-analyse the results and chase some new dreams. I know this will be popular, but I believe the Board should at least consider an alternative path: sell the IP, absorb the exit costs, sell the company shell, and returning the remaining cash to shareholders. I’d at least love to understand what this scenario looks like compared to the current share price and the slim potential for a material rebound.
- Forums
- ASX - By Stock
- PER
- Ann: Topline Six-Month Results From Phase IIb Study of Avicursen
PER
percheron therapeutics limited
Add to My Watchlist
0.00%
!
1.0¢

Ann: Topline Six-Month Results From Phase IIb Study of Avicursen, page-111
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.87M |
Open | High | Low | Value | Volume |
1.2¢ | 1.3¢ | 1.0¢ | $277.9K | 24.26M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 2273797 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 5066000 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 2273797 | 0.010 |
8 | 6438144 | 0.009 |
3 | 975000 | 0.008 |
3 | 1585000 | 0.007 |
1 | 1000000 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 5066000 | 5 |
0.012 | 2840824 | 7 |
0.013 | 500000 | 2 |
0.014 | 1572000 | 3 |
0.015 | 2134549 | 2 |
Last trade - 16.14pm 26/06/2025 (20 minute delay) ? |
Featured News
PER (ASX) Chart |
The Watchlist
3DA
AMAERO LTD
Hank Holland, Chairman & CEO
Hank Holland
Chairman & CEO
Previous Video
Next Video
SPONSORED BY The Market Online